Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 3/20 | 0.48 |
| ▸ | CNR2 | P34972 | 3/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 8/20 | 0.42 |
| ▸ | CA2 | P00918 | 8/20 | 0.42 |
| ▸ | CA9 | Q16790 | 7/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | SCN1A | P35498 | 2/20 | 0.41 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.41 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 3/20 | 0.40 |
| ▸ | CA7 | P43166 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18141734 | 1.00 | CNR1 (0.48) | CNR1CNR2CYP2C9CA1CA2 | |
| SCHEMBL1517644 | 1.00 | CNR1 (0.48) | CNR1CNR2CYP2C9CA1CA2 | |
| SCHEMBL5959275 | 1.00 | CNR1 (0.48) | CNR1CNR2CYP2C9CA1CA2 | |
| SCHEMBL18141533 | 1.00 | CNR1 (0.48) | CNR1CNR2CYP2C9CA1CA2 | |
| SCHEMBL18141761 | 1.00 | CNR1 (0.48) | CNR1CNR2CYP2C9CA1CA2 | |
| SCHEMBL10884726 | 1.00 | CNR1 (0.48) | CNR1CNR2CYP2C9CA1CA2 | |
| SCHEMBL18139481 | 1.00 | CNR1 (0.48) | CNR1CNR2CYP2C9CA1CA2 | |
| SCHEMBL18140579 | 1.00 | CNR1 (0.48) | CNR1CNR2CYP2C9CA1CA2 | |
| SCHEMBL4958799 | 1.00 | CNR1 (0.48) | CNR1CNR2CYP2C9CA1CA2 | |
| SCHEMBL18141350 | 1.00 | CNR1 (0.48) | CNR1CNR2CYP2C9CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3874952-B1 | HERBICIDE COMPOSITION | KAO CORP (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-12225902-B2 | Herbicide composition | KAO CORPORATION (JP) | 2025-02-18 | — | — | US | disclosed |
| EP-3550030-B1 | METHOD FOR MEASURING GLYCATION RATE OF HEMOGLOBIN | TOYO BOSEKI (JP) | 2025-01-01 | — | — | EP | disclosed |
| US-12091597-B2 | Method for preparing quantum dot film, quantum dot film prepared thereby, and wavelength conversion sheet and display comprising same | INNO QD CO., LTD (KR) | 2024-09-17 | — | — | US | disclosed |
| US-11958920-B2 | Active energy ray curable composition | ASIA STENCIL PAPER CO., LTD. (JP) | 2024-04-16 | — | — | US | disclosed |
| EP-3303286-B1 | COMPOUNDS THAT BIND TO RELA OF NF-KB FOR USE IN TREATING CANCER | CEDARS SINAI MEDICAL CENTER (US) | 2023-10-04 | — | — | EP | disclosed |
| US-11634627-B2 | Method for manufacturing quantum dot film comprising encapsulated quantum dots uniformly dispersed therein, quantum dot film manufactured thereby and wavelength conversion sheet and display comprising same | INNO QD CO., LTD (KR) | 2023-04-25 | — | — | US | disclosed |
| US-20220298269-A1 | Active Energy Ray Curable Composition | ASIA STENCIL PAPER CO., LTD. (JP) | 2022-09-22 | — | — | US | disclosed |
| EP-3874952-A1 | HERBICIDE COMPOSITION | Kao Corporation (JP) | 2021-09-08 | — | — | EP | disclosed |
| US-20210251219-A1 | HERBICIDE COMPOSITION | KAO CORPORATION (JP) | 2021-08-19 | — | — | US | disclosed |
| US-6916861-B2 | Pigment containing ink and production method thereof | CANON KABUSHIKI KAISHA (JP) | 2005-07-12 | — | — | US | disclosed |
| WO-2004096188-A1 | POLYHYDROXYALKANOATE-CONTAINING MAGNETIC STRUCTURE, AND MANUFACTURING METHOD AND USE THEREOF | CANON KABUSHIKI KAISHA (JP) | 2004-11-11 | — | — | WO | disclosed |
| EP-1277464-B1 | Liposome coated with polyhydroxyalkanoate and production method thereof | CANON KK (JP) | 2004-10-06 | — | — | EP | disclosed |
| US-6686411-B2 | MOLDING MATERIAL OF VINYL CHLORIDE POLYMER, A CROSSLINKED GRAFTED, ACRYLIC RUBBER, A METHYL METHACRYLATE HAVING A SPECIFIC VISCOSITY AND CALCIUM CARBONATE; WINDOW AND DOOR FRAMES; WEATHERPROOFING, IMPACT STRENGTH; GLOSS; EXTRUSION | KANEKA CORPORATION (JP) | 2004-02-03 | — | — | US | disclosed |
| EP-1209196-B1 | VINYL CHLORIDE RESIN COMPOSITION | KANEKA CORP (JP) | 2003-11-05 | — | — | EP | disclosed |
| US-20030203987-A1 | Pigment containing ink and production method thereof | CANON KABUSHIKI KAISHA (JP) | 2003-10-30 | — | — | US | disclosed |
| US-20030113368-A1 | Liposome coated with polyhydroxyalkanoate and production method thereof | CANON KABUSHIKI KAISHA (JP) | 2003-06-19 | — | — | US | disclosed |
| EP-1256606-A2 | Pigment containing ink and production method thereof | CANON KABUSHIKI KAISHA (JP) | 2002-11-13 | — | — | EP | disclosed |
| US-20020165311-A1 | Vinyl chloride resin composition | KANEKA CORPORATION (JP) | 2002-11-07 | — | — | US | disclosed |
| EP-1209196-A1 | VINYL CHLORIDE RESIN COMPOSITION | Kaneka Corporation (JP) | 2002-05-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030113368-A1 | Liposome coated with polyhydroxyalkanoate and production method thereof | LIPA, ABHD16A, LIPE | CNR1 1026/4885CNR2 691/4885CYP2C9 1647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.